BioSpace News Archive

Medical device incubator and technology brokerage firm, Hatch Medical, L.L.C. announced recently that it has entered into an exclusive brokerage relationship with inventor and CEO, Dr. Robert Ward, MB BS FRCS FRCR and his company, Fixit Medical, Ltd. Hatch Medical will seek to sell or out-license Dr. Ward’s next generation drainage catheter fixation device, Cingo™.

Waters Corporation announced fourth quarter 2020 sales of $787 million, a 10% increase as reported, compared to sales of $716 million for the fourth quarter of 2019.

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted seven newly-hired employees inducement options to purchase an aggregate of 137,500 shares of BioCryst common stock on January 29, 2021 as inducements material to each employee entering into employment with BioCryst.

Upjohn Business (1) Now Accounted for as a Discontinued Operation for All Periods Presented, Excluded from Adjusted (2) Results Full-Year 2020 Revenues of $41.9 Billion, Which Now Exclude Upjohn (1) , Reflect 3% Operational Growth; When the Impact from Consumer Healthcare (1) and the $154 Million of Sales of BNT162b2 are Excluded, Full-Year 2020 Revenues Grew 8% Operationally

To help more patients with rheumatoid arthritis (RA), Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today launched the new Vectra ® Cardiovascular Risk assessment that can predict the risk for cardiovascular (CV) events in patients with RA.

Sparsentan achieved statistically significant response on interim proteinuria endpoint compared to irbesartan after 36-weeks of treatment To date in the study, sparsentan has been generally well-tolerated and has shown a safety profile comparable to irbesartan Company to host conference call and webcast today at 8:30 a.m. ET

The American Academy of Facial Plastic and Reconstructive Surgery, the world’s largest association of facial plastic surgeons, released its 2020 member survey results.

Spectra Medical Devices, Inc. has exciting news to share, our new e-commerce site is now live. “We are proud to offer customers worldwide a new way to shop for our products safely and conveniently. Qualified customers with proper licensing can easily and securely register at our e-commerce site.

Multiple data presentations to show long-term benefit and consistency of ERLEADA® (apalutamide) in advanced prostate cancer; oral presentations to highlight Phase 3 ACIS, TITAN and SPARTAN study results

Bausch Health Companies Inc. and its dermatology business, Ortho Dermatologics, one of the largest prescription dermatology health care businesses, announced the opening of the application process for its 2021 Aspire Higher scholarship program.